$HIPH NEWS OUT ~ American Premium Water Corp. (HIPH)

New Post Public Reply Private Reply Replies (0) Message Board
trooperstocks
71
$HIPH NEWS OUT ~ American Premium Water Corp. (HIPH) Outlines Wholesale Sales Strategy After Successful Launch of Canna Nano CBD Water Collaboration
ACCESSWIRE ACCESSWIRENovember 12, 2018
CEO Ryan Fishoff will be in Las Vegas this week at the Marijuana Business Conference & Expo

PLAYA VISTA, CA / ACCESSWIRE / November 12, 2018 / American Premium Water Corporation (OTC PINK: HIPH) is outlining its national sales strategy in advance of the 2018 Marijuana Business Conference & Expo in Las Vegas, NV (MJBIZ) which will be attended by CEO and Interim Chairman Ryan Fishoff. This comes after two weeks after the launch of the Company's CBD water collaboration with Canna Nano, which has sold over three hundred and fifty bottles since the release on Singleseed.com, the wholly owned subsidiary of Singlepoint, Inc, (SING).

View photos
The Company has identified four geographic markets that it will be focusing its efforts to expand its wholesale brick and mortar strategy; the New York City metropolitan area, the Los Angeles metropolitan area, the Las Vegas metropolitan area, and the Miami/South Florida metropolitan area. These four markets will be the core of a nationwide rollout strategy that will commence at MJBIZ, where Mr. Fishoff will be attending and meeting with distributors and wholesalers.

"I am really excited for the MJBIZ conference this week in Las Vegas. I already have a packed schedule of meetings and events with potential wholesalers and distributors. The meetings will be about supporting the Company's wholesale strategy. These locations were chosen not only for their size and media presence but also the Company's ability to successfully execute in them. Managements familiarity with these are a strategic advantage. Acquiring distribution is only part of the Company's strategy to solidify market share; local events are being planned in coordination with social media marketing programs that will be rolling out in the coming weeks to support the "ground game" efforts in growing retail distribution. Other markets, including Canada remain a focus for the Company, and we will detail our plans for those areas in coming weeks as well" commented Mr. Fishoff.

"I love events like MJBIZ where there is so much energy in the building and you feed off it. It's a full sprint where you try to meet as wide a spectrum of companies and try to arrange as many meetings as possible to maximize productivity. At big conferences (MJBIZ) there are always one or two meetings that happen out of the blue; they usually surprise you for what comes out of them. I generally like to keep an open mind attending these because you never know what could come out of even the most non-descript interaction. The primary goal of the week is to expand our distribution and business development activities. I look forward to reporting the Company's progress and a full overview of the conference to our shareholders in short order." added Mr. Fishoff.

American Premium had announced in October that it completed its first third-party distribution deal with SinglePoint, Inc (SING). The Company announced later in the month that it had collaborated with the CBD products brand Canna Nano (www.cannananocbd.com) which is being sold on Singleseed.com. These developments have further established the Company as premier player in the CBD sector, which has caught the attention of Zacks Investment Research, whom began coverage of the Company. Zacks, sporadically covers stocks in the OTC and does not provide coverage for the Company's competitors such as Puration, Inc (PURA), Kona Gold Solutions, Inc ( KGKG) or Elev8 Brands Inc, (VATE). Zacks recently upgraded its investment outlook for the Company, along with New Age Beverage ( NBEV).

"We have been extremely happy so far with our partnership with American Premium. The Lalpina products have sold very well without advertising or any promotion. Over the next few weeks, SinglePoint plans to expand its online presence through various ad networks to increase traffic, and in turn, sales of Lalpina CBD water through the portal." Stated Wil Ralston, President, SinglePoint, Inc.

"I have been extremely happy with our partnership with SinglePoint so far. They have been great and it's been mutually beneficial relationship. I look forward to taking some time at MJBIZ to sit down with them (SING) and figure out more ways the two companies can work together. We are still working on our other acquisition initiatives. A lot of great things are happening with the Company, I'm glad Zacks took notice and shares the long-term view. Right now, we're trying to stay focused on growing sales and executing the strategic acquisitions we have previously discussed. As always, as soon as there are developments, we will share those with the investment community." added Mr. Fishoff.

About American Premium Water Corp.

American Premium Water (OTC PINK: HIPH) is a diversified luxury consumer products company focused on businesses in the health and beauty and biotech sectors. The company is focused on harnessing the powers of hydrogen and Nano technologies paired with cannabidiol (CBD) to treat health disorders and enhance quality of life. This business model aims to market emerging fashion brands by leveraging classic retail partners and incorporating disruptive block chain technologies to expand the retail footprint. The company's portfolio includes the LALPINA Hydro and LALPINA Hydro CBD brands (www.LalpinaInc.com), Gents, Worthy, and blockchain platform FashionCoinX (www.FashionCoinX.com).
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Class Action Greenlighted Against Concordia for Title IX Violations

Updated Category News Views 87

Paving the Way for Equality in Campus Sports Ah, courts and colleges—two institutions you'd hope would play by the rules. But here we are, knee-deep in a legal battle with Concordia University Irvine (CUI) caught in the crosshairs of Title IX compliance issues. No surprise there when a federal court finally gave the nod for a class action to plow ahead. Class Action...

Continue Reading
AppLovin Legal Woes: A Deep Dive into Investor Claims

Updated Category News Views 104

AppLovin Faces Legal Heat and Market Scrutiny Bitter truth has a way of crashing like a wave, and AppLovin (NASDAQ: APP) is feeling the brunt of it. Now knee-deep in a securities class action, the firm’s been accused of selling fairy tales about its AI capabilities, leaving investors clutching at substantial losses. If you’ve been banking on their promises between...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 149

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 118

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 202

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Novo's CagriSema Trial Shows Promising Obesity Results

Updated Category News Views 162

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Continue Reading
Novo's Research Unlocks New Insights into Food Noise

Updated Category News Views 179

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....

Continue Reading
Maritime Safety Urged After New Orleans Vessel Incident

Updated Category News Views 109

The Mississippi River saw a bit of drama near the Port of New Orleans when a river cruise turned into an unexpected rescue operation. Listen up, because incidents like this bring maritime safety right to the forefront; we can't ignore the waters that shape our daily lives here in the Big Easy. Navigating the Waters Safely Some 150 souls found themselves in a pickle when...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading